Catheter-directed therapy in pulmonary embolism

Area of Science:

• Cardiology
• Pulmonology
• Interventional Radiology

Background:

• Acute pulmonary embolism (PE) is a life-threatening condition with significant mortality and long-term complications.
• Systemic thrombolysis has been the primary treatment for hemodynamically unstable PE patients for decades.
• Interventional therapies for PE are emerging as a promising alternative.

Purpose of the Study:

• To review the current landscape of interventional therapies for acute pulmonary embolism.
• To evaluate the safety and efficacy of these novel approaches based on existing evidence.
• To discuss the limitations and future directions for interventional PE treatment.

Main Methods:

• Review of existing literature on interventional devices and studies for acute pulmonary embolism.
• Analysis of safety and efficacy data from nonrandomized studies of intermediate or high-risk PE patients.
• Discussion of the current evidence limitations and recommendations for clinical decision-making.

Main Results:

• Multiple interventional devices have been developed for PE, including local thrombolysis, fragmentation, and aspiration.
• Preliminary data from small, nonrandomized studies suggest promising safety and efficacy for intermediate or high-risk PE.
• A lack of adequately powered randomized trials currently prevents interventional PE treatment from being standard-of-care.

Conclusions:

• Interventional therapy for acute pulmonary embolism shows potential but requires further robust evidence from randomized trials.
• Treatment decisions should be individualized, considering patient status, bleeding risk, local expertise, and available devices.
• Multidisciplinary PE response teams are recommended to optimize patient management and treatment strategies.